Sorrento Hits Snag On $200M Scilex Stock Sale In Ch. 11

By Vince Sullivan · August 1, 2023, 7:27 PM EDT

Bankrupt drug developer Sorrento Therapeutics told a Texas judge Tuesday that its planned $200 million sale of its equity in nondebtor subsidiary Scilex Holding Co. had hit a snag, forcing the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login